Tailoring treatments using treatment effect modification

A F Schmidt, O H Klungel, M Nielen, A de Boer, R H H Groenwold, A W Hoes

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)

Abstract

BACKGROUND AND OBJECTIVE: Applying results from clinical studies to individual patients can be a difficult process. Using the concept of treatment effect modification (also referred to as interaction), defined as a difference in treatment response between patient groups, we discuss whether and how treatment effects can be tailored to better meet patients' needs.

RESULTS: First we argue that contrary to how most studies are designed, treatment effect modification should be expected. Second, given this expected heterogeneity, a small number of clinically relevant subgroups should be a priori selected, depending on the expected magnitude of effect modification, and prevalence of the patient type. Third, by defining generalizability as the absence of treatment effect modification we show that generalizability can be evaluated within the usual statistical framework of equivalence testing. Fourth, when equivalence cannot be confirmed, we address the need for further analyses and studies tailoring treatment towards groups of patients with similar response to treatment. Fifth, we argue that to properly frame, the entire body of evidence on effect modification should be quantified in a prior probability.

Original languageEnglish
Pages (from-to)355-62
Number of pages8
JournalPharmcoepidemiology and Drug Safety
Volume25
Issue number4
DOIs
Publication statusPublished - Apr-2016
Externally publishedYes

Keywords

  • Clinical Trials as Topic
  • Health Services Needs and Demand
  • Humans
  • Precision Medicine
  • Randomized Controlled Trials as Topic
  • Research Design
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Cite this